Cancer Institute A national cancer institute
designated cancer center

March 2010 Funding Opportunities

DoD Fiscal Year 2010 Breast Cancer Research Program

Full Program Announcements, Application Instructions and deadlines are available on the CDMRP website: http://cdmrp.army.mil/funding/bcrp.htm

All upcoming DoD CDMRP programs: http://cdmrp.army.mil/funding/reftable.htm

The Fiscal Year (FY) Department of Defense 2010 Appropriation included $150 million for the Breast Cancer Research Program (PCRP).  

New for FY10: BCRP Overarching Challenges
The BCRP challenges the scientific community to design innovative research that will foster new directions for, address neglected issues in, and bring new investigators to the field of breast cancer research. The BCRP focuses its funding on innovative projects that have the potential to make a significant impact on breast cancer, particularly those involving multidisciplinary and/or multi-institutional collaborations. The BCRP encourages risk-taking research; however, all projects must demonstrate solid judgment and rationale.

BCRP Pre-doctoral Traineeship Award
Purpose
: The Pre-doctoral Traineeship Award supports the training of promising graduate students studying breast cancer under the guidance of a designated mentor to prepare them for successful careers in breast cancer research. Under this award mechanism, the pre-doctoral trainee is considered the Principal Investigator (PI) and, as such, should write the application with appropriate direction from the mentor. The mentor, who may be a junior or senior faculty member, must clearly demonstrate a commitment to guiding the PI’s research and training,
and must have a track record in breast cancer research. If the mentor is not an experienced breast cancer researcher, then a formal co-mentorship by an established breast cancer researcher is required.
Eligibility:   The Pre-doctoral Trainee is the PI for this award.  PIs must be graduate students enrolled in a PhD or MD/PhD program
Amount of funding: Up to $40,000 per year can be requested in direct costs for up to 3 years; direct costs in excess of the stipend must be used for direct support for the PI and may not be used for research costs.  Indirect costs may be proposed for up to 8%. The Pre-doctoral Traineeship Award should support the PI during dissertation research only.
Deadlines:
Pre-Application through http://cdmrp.org <http://cdmrp.org> required and due: March 24, 2010, 5 pm Eastern Time.
Confidential letters of recommendation:  April 7, 2010
Application due April 7, 2010, 11:59 pm Eastern Time via grants.gov

BCRP Postdoctoral Fellowship
Purpose: The Postdoctoral Fellowship Award supports exceptionally talented recent medical or other doctoral graduates performing innovative, high-impact breast cancer research during their postdoctoral training, and allows them to obtain the necessary experience for an independent career at the forefront of breast cancer research. Candidates for this award should exhibit a strong desire to pursue a career in breast cancer research. While the PI is not required to have previous experience in breast cancer research, this proposal must focus on breast cancer research. Proposals must emphasize the PI’s high potential for success in becoming an independent breast cancer researcher based on his/her qualifications, achievements, and letters of recommendations. The mentor (or co-mentor, if applicable) must possess the appropriate expertise and experience in breast cancer, to include peer reviewed breast cancer funding and publications, and clearly demonstrate a commitment to guiding the PI’s research and training. The proposal should include information about the mentor’s experience in conducting innovative research and how he/she intends to support the PI’s innovative breast cancer research endeavors. If the mentor is not an experienced breast cancer researcher, then a formal co-mentorship by an established breast cancer researcher is required.
Amount of funding: $100,000 in direct costs/year for up to 3 yrs
Eligibility:  Under this award mechanism, the postdoctoral trainee is considered the Principal Investigator and, as such, should write the project narrative with appropriate direction from the mentor. As of the application submission deadline, all eligible PIs must have:
Been in the laboratory, in which this research is to be performed, for no more than 2 years,
A total of less than 4 years of postdoctoral research experience (excluding clinical residency or fellowship training), and
Successfully completed the requirements for a doctoral or medical degree.
Deadlines:
Pre-Application through http://cdmrp.org <http://cdmrp.org> required and due: March 24, 2010; 5 pm Eastern Time.
Confidential letters of recommendation:  April 7, 2010
Application due April 7, 2010, 11:59 pm Eastern Time via grants.gov

BCRP Inter-Institutional Training Award
The overarching goal of this award mechanism is to establish the foundations for breast cancer research programs at academic institutions where they currently do not exist. This will be accomplished through focused mentoring and training of two or more faculty-level investigators who have limited or no experience in breast cancer research, participating in research collaborations with experienced breast cancer investigators. The PI and co-PIs must indicate a commitment to becoming competitive breast cancer researchers and to the establishment of a breast cancer research program at their institution.
This award provides mentorship and training at an institutional level by supporting collaborations between:
• Multiple investigators at an academic institution that does not have an established breast cancer research program (i.e. having limited funding and/or resources in breast cancer research); and
• At least one experienced breast cancer researcher (Primary Collaborating Mentor) at a different research institution, which has a well-established breast cancer research program.
Amount of funding: The maximum allowable funding for the entire period of performance is $1M in direct costs for a period of up to 4 years.
Eligibility:  Faculty with PI eligibility. The PI and co-PI(s) each must have a doctoral degree (PhD, MD or equivalent) and hold a faculty position (Assistant Professor or higher) at an academic institution without a breast cancer program. The applicant institution must have received no more than $500,000 in aggregate during the past three calendar years (2006-2009) in non-mentored federal funding for breast cancer research The Primary Collaborating Mentor must be part of an established breast cancer research program at a different institution as evidenced by his/her record in acquiring funding for breast cancer research, and experience in training breast cancer researchers.
Deadlines:
Pre-Application through http://cdmrp.org <http://cdmrp.org> required and due: March 18, 2010, 5:00 pm Eastern Time.
Invitation to Submit an Application: April 2010
Full application (by invitation only):  June 23, 2010 11:59 pm EST via grants.gov

BCRP Idea Award
Purpose: The Idea Award is designed to promote new ideas that are still in the early stages of development and have the potential to yield highly impactful data and new avenues of investigation. This mechanism supports conceptually innovative, high-risk/high-reward research that could ultimately lead to critical discoveries or major advancements that will accelerate the eradication of breast cancer. Research projects should include a well-formulated, testable hypothesis based on strong scientific rationale. The BCRP seeks applications from all areas of basic, translational, clinical, behavioral, and epidemiological research. Presentation of preliminary data is not consistent with the intent of the Idea Award mechanism. While the inclusion of preliminary data is not prohibited, the strength of the application should not rely on preliminary data.
COLLABORATIVE OPTION: The Idea Award mechanism encourages applications that include meaningful and productive collaborations between two investigators. The Collaborative Option under the Idea Award mechanism is structured to accommodate two PIs. The Initiating and Partnering PI each have different submission requirements; however, both PIs should contribute to the preparation of a single application. The collaborative partners may have expertise in similar or disparate scientific disciplines but are expected to bring different strengths to the application. New collaborations are encouraged, but not required. The Collaborative Option is designed to support collaborations on completely new research ideas; therefore, merely continuing an existing or previous collaborative research project between two investigators is not considered innovative and does not meet the intent of the Idea Award mechanism.
Eligibility:  Stanford faculty with PI eligibility.   Special note:  even though the guidelines state postdoctoral trainees may apply, because this is a research grant, Stanford policy only permits Stanford faculty with PI eligibility to apply.
Amount of funding:
Single PI:  Maximum funding amount of $375,000 direct costs for up to 2 yrs.
Collaborative option: A separate award will be made to each PI’s institution. Maximum allowable, combined funding for the entire period of performance is $550,000 for direct costs for up to 2 yrs.
Applications with population-based studies (either single or collaborative PIs): Maximum period of performance is 5 years. Maximum allowable funding for the entire period of performance is $750,000 for direct costs. Applications with the Collaborative Option or population-based studies must include a compelling justification for requesting the increased levels of funding that are allowed.
Deadlines:
Pre-Application through http://cdmrp.org <http://cdmrp.org> required and due: April 21, 2010, 5 pm Eastern Time.
Full application: May 5, 2010 11:59 pm Eastern Time via grants.gov

The BCRP Multi-Team Award
Purpose:
supports the creation of a collaborative research project among three teams, each led by a Principal Investigator (PI) with a history of creativity and innovation, to focus on a critical area of breast cancer. The Multi-Team Award should create an environment that fosters and supports innovation and creativity, with consistent, intensive interaction across teams in a way that engages all members of the teams in all aspects of the research project. The multi-team approach is expected to transform the research process through the integration of basic and clinical disciplines, substantive cross-disciplinary training among the scientists on the teams, and integral participation of consumer advocates. The requirements for this award are as follows:
Research Question: Research proposed under the Multi-Team Award must focus on a question of significant importance to breast cancer that has been inadequately addressed, or for which there may be an absence of an established paradigm or technical framework. The research question should address overarching issues that have broad implications for the disease and risk management (e.g., risk factors, dormancy) and not focus merely on the study of specific pathways or genes. Clinical research (may include clinical trials) must be included as part of the proposed work.
Eligibility: Stanford faculty with eligibility.
Teams of Scientists and Consumers: The Multi-Team Award supports the collaborative efforts of three teams consisting of scientists and consumer advocates. The three PIs, one for each team, must include one basic scientist, one clinician, and one additional individual from any appropriate area of expertise (eg, epidemiology).
At least two different institutions must be represented by the three PIs.
Each of the three PIs is expected to have a track record of innovation and creativity, and be well qualified to lead his/her respective team in this intensive collaboration. The collaborating PIs should work together to develop the research plan, determine the management structure, and prepare the application. It should be clear that all PIs have an equal level of intellectual input into the proposed project. Collectively, the members of the teams should represent the appropriate diversity of expertise necessary for addressing the research question. Effort is expected to be balanced among the three teams, unless otherwise justified.
Consumer Advocates: Each PI’s team must include one or more breast cancer consumer advocates who will be integrally involved throughout the planning and implementation of the research project and management of the collaboration.
Amount of funding: A maximum of $4.5 million in direct costs for up to 4 years.
Deadlines:
Pre-Application through http://cdmrp.org <http://cdmrp.org> required and due: March 18, 2010, 5 pm Eastern Time.
Invitation to Submit an Application: April 2010
Full application (by invitation only):  June 23, 2010, 11:59 pm EST via grants.gov

The BCRP Transformative Vision Award
Purpose:
supports research projects to realize an extraordinary vision for dramatically affecting the prevention or treatment of breast cancer, and a plan to test and achieve the vision as quickly as possible.
The critical components of this award mechanism are:
Vision
: The most important aspect of the Transformative Vision Award is the articulation of the vision for a new approach to significantly impact the prevention or treatment of breast cancer. The final impact may be near-term or long-term, but the success of the vision must be transformative on breast cancer. A careful presentation of the state-of-the-art, and how the vision will transform this state, must be described.
The Transformative Vision Award will be supported in two phases. Phase I will enable the team to lay the groundwork for the research project and to test the basic concepts of the vision. Phase II will allow the expansion of the project to proceed to accomplishment of the vision.
Eligibility:  
Stanford faculty with PI eligibility
Amount of funding: a maximum of $12 million in direct cost for up to 5 years.
Phase I funding: The applicant may request up to $2M in direct costs for years 1 and 2 (Phase I). Phase I will be funded using allocations from the FY10 BCRP congressional appropriation.
Phase II funding: A combined total of $10M in direct costs may be requested for option years 3, 4, and 5 (Phase II). Option years will be funded with future congressional appropriations, if available. A total of three option years will be allowed. Exercising the options for continued performance in Phase II will be contingent on receipt of sufficient congressional appropriations to the BCRP, submission and approval of written progress reports, and acceptable performance of the awardee.
The applicant must submit a comprehensive budget that details the projected funding needed for the entire period of performance, to include Phases I and II.
The applicant may request the entire maximum direct cost amount for a project that may be less than the maximum 5-year period of performance.
Deadlines:
Pre-Application through http://cdmrp.org <http://cdmrp.org> required and due: March 18, 2010, 5 pm Eastern Time.
Invitation to Submit an Application: April 2010
Full application (by invitation only):  June 23, 2010, 11:59 pm EST via grants.gov

The Department of Defense (DoD) Peer Reviewed Medical Research Program (PRMRP)
Download Program Announcements, Application Instructions and deadlines: http://cdmrp.army.mil/funding/prmrp.htm <http://cdmrp.army.mil/funding/prmrp.htm> .  

The Synopsis Table for all upcoming DoD CDMRP programs: http://cdmrp.army.mil/funding/reftable.htm <http://cdmrp.army.mil/funding/reftable.htm>

Eligibility for all announcements: Stanford faculty with PI eligibility
The objectives of the FY10 PRMRP are to identify and fund the best medical research to protect and support war-fighters, veterans, and all beneficiaries, and to eradicate diseases that impact these populations. The PRMRP challenges the scientific and clinical communities to address one of the FY10 congressionally directed topic areas with original ideas that foster new directions in basic science and translational research; novel product development leading to improved therapeutic or diagnostic tools, or improvements in clinical policies/guidelines; or clinical trials that address an immediate clinical need.   
Disease Topics
All applications for PRMRP funding must specifically and clearly address at least one of the following topic areas as directed by Congress, and must have direct relevance to the health care needs of the Armed Forces, their family members, and/or the U.S. veteran population.
 
Chronic Migraine and Post-traumatic Headache
Dystonia
Drug Abuse
Epilepsy
Fragile X Syndrome
Inflammatory Bowel Disease
Interstitial Cystitis
Listeria vaccine for infectious disease
Lupus
Mesothelioma
Neuroblastoma
Osteoporosis and related bone disease
Paget’s Disease
Pheochromocytoma
Polycystic Kidney Disease
Post-traumatic Osteoarthritis
Scleroderma
Social Work Research
Tinnitus

The PRMRP seeks applications in laboratory, clinical, behavioral, and epidemiologic research, as well as public health and policy; environmental sciences; nursing; occupational health; alternative therapies; ethics; economics; and strategic research, such as studies designed to shape the development of or to validate clinical policy or guidance. Interdisciplinary and integrative health approaches are welcomed.
 
Encouraged DOD alignment: Relevance to the health care needs of the Armed Forces, their family members, and/or the U.S. veteran population is a key feature of these awards. Therefore, PIs are strongly encouraged to collaborate, integrate, and/or align their research projects with military and/or VA research laboratories and programs.  Websites which may be useful in identifying information about ongoing DOD areas of research interest within the FY10 PRMRP topic areas are listed in the Program Announcement.
 
DoD Peer Reviewed Medical Research Program:  The Fiscal Year (FY) DoD 2010 Appropriation included $50 million for the Peer Reviewed Medical Research Program. The following funding mechanisms, summarized below, are offered.  

PEER REVIEWED MEDICAL RESEARCH PROGRAM FUNDING MECHANISMS:
Please note that any FY10 mechanism may address any one or more of the above listed topic areas.
Clinical Trial Award
Concept Award
Investigator-Initiated Research Award
Technology/Therapeutic Development Award
 
1) Clinical Trial Award (CTA)
The intent of the PRMRP CTA award is to support the rapid implementation of clinical trials of interventions with the potential to have a significant impact on a disease or condition addressed in at least one of the congressionally directed FY10 PRMRP topic areas.
Eligibility: PIs at or above the level of Assistant Professor (or equivalent) (faculty with PI eligibility) are eligible to submit applications; multi-institutional clinical trials are allowed; collaboration with VA researchers and/or clinicians is encouraged, however, use of military populations is not a prerequisite;  all applications must specifically and clearly address the military relevance of the proposed research; award cannot be used to support preclinical research studies.  
Amount of funding:Maximum funding is $2.2 Million in direct costs plus indirect costs; period of performance cannot exceed five (5) years.
Deadlines:
PRMRP Clinical Trial Award (CTA):
Pre-Application (Letter of Intent) through http://cdmrp.org <http://cdmrp.org> required and due: April 22, 2010, 5 pm Eastern Time.
Application due May 13, 2010, 11:59 pm Eastern Time via grants.gov

2) Concept Award (CA)
The intent of the PRMRP CA is to support the exploration of a highly innovative new concept or untested theory that addresses an important problem relevant to at least one of the FY10 PRMRP topic areas.  Innovation and novelty of the concept are the most important aspects of this award mechanism. Inclusion of preliminary data is strongly discouraged. This award is not intended to support ongoing work; therefore, the existence and presentation of preliminary data suggests that the proposed research would be more appropriately submitted to a different award mechanism.
Eligibility: Stanford faculty with PI eligibility (even though the guidelines state this is open to all investigators, Stanford policy permits only faculty with PI eligibility to apply because this is a research grant.)
Interesting features of the Peer Reviewed Medical Concept Awards include: the application project narrative is limited to one page, clinical trials are not allowed, peer reviewers are blinded as to identity of Principal Investigator (PI) and PI’s institution/organization,  
Amount of funding: Maximum funding of $75,000 in direct costs, plus indirect costs, period of performance cannot exceed one (1) year.
Deadlines:
PRMRP Concept Awards (CA):
Pre-Application (Letter of Intent) through http://cdmrp.org <http://cdmrp.org> required and due: March 25, 2010, 5 pm Eastern Time.
Application due April 8, 2010, 11:59 pm Eastern Time via grants. gov

3) Investigator-Initiated Research Award (IIRA)
The intent of the PRMRP IIRA is to support studies that will make an important contribution toward understanding mechanisms of initiation, or progression of and/or improving patient care for a disease or a condition related to at least one of the congressionally directed FY10 PRMRP topic areas.
Interesting features of the Peer Reviewed Medical Investigator-Initiated Research Awards include:
Eligibility: PIs at or above the level of Assistant Professor (or equivalent) are eligible to submit applications; Partnering-PI option using a multi-institutional approach; clinical trials are not allowed; research projects may focus on any phase of research from basic laboratory research through translational research,  
Amount of funding: Maximum funding of $725,000 in direct costs, period of performance cannot exceed 3 years.
Deadlines:
PRMRP Investigator-Initiated Research Award (IIRA):
Pre-Application (Pre-proposal) through http://cdmrp.org <http://cdmrp.org> required and due: March 11, 2010, 5 pm Eastern Time.
Pre-Application (including Pre-proposal narrative with 2-page limit) will be screened by peer review and submission of full application is by PRMRP invitation.
Invitations from the PRMRP to selected pre-applications: June 2010
Application due August 5, 2010, 11:59 pm Eastern Time via grants.gov

4) Technology/Therapeutic Development Awards (TTDA)
The intent of the PRMRP TTDA is to provide support for the translation of promising preclinical findings into products for clinical applications in at least one of the congressionally directed FY10 PRMRP topic areas.  The product(s) to be developed may be pharmacologic agents (drugs or biologicals), devices, and/or clinical guidance. The PI must provide a transition plan (including potential funding and resources) showing how the product will progress to clinical trials and/or delivery to the military or civilian market after the completion of the PRMRP award.
Interesting features of the Peer Reviewed Medical Technology/Therapeutic Development Awards include:
Eligibility: PIs at or above the level of Assistant Professor (or equivalent) are eligible to submit applications; clinical trials are not allowed.  
Amount of funding: Maximum funding of $1.7 Million in direct costsplus indirect costs, period of performance cannot exceed 4 years.
Deadlines:
PRMPR  Technology/Therapeutic Developoment Awards (TTDA):
Pre-Application ( Letter of Intent) through http://cdmrp.org <http://cdmrp.org> required and due: April 22, 2010; 5 pm Eastern Time.
Application due May 13, 2010, 11:59 pm Eastern Time via grants.gov

PCRP Exploration-Hypothesis Award:
Purpose:
supports the exploration of highly innovative, untested, high-risk/high-gain concepts, theories, paradigms and/or methods
that address an important problem in prostate cancer. Results of studies conducted through this award may provide the scientific rationale upon which a new hypothesis can be based, or
initial proof-of-principle of an innovative hypothesis. This award is designed to provide investigators the opportunity to pursue serendipitous observations that may reveal entirely new
avenues for investigation. Presentation of preliminary data is not allowed. However, logical reasoning and a sound scientific rationale for the proposed work must be provided.
Interesting features of the PCRP Exploration-Hypothesis Development Award include:  emphasis on innovation, preliminary data not allowed, no clinical trials, reviewers will be blinded to
the identity of the PI, collaborators, and their organizations, Application Project Narrative limited to 1 page.  
Eligibility:  Stanford faculty with PI eligibility;
Special note: even though the guidelines states that it is open to post-docs and above, because this is a research grant, Stanford policy only permits Stanford faculty with PI eligibility to
apply)
Amount of funding: Maximum funding of $75,000 for direct costs plus indirect costs, for a period of performance of up to one (1) year.
Deadlines:
Pre-Application (Letter of Intent) through http://cdmrp.org <http://cdmrp.org> required and due: March 10, 2010; 5 pm Eastern Time.
Application through due March 31, 2010, 11:59 pm EST via grants.gov

PCRP Impact Award
Purpose: This award will support research projects specifically focused on making a major impact on one critical issue in prostate cancer:  reducing or eliminating the over-treatment of
primary prostate cancer.  Principal Investigators (PIs) applying for the Impact Award are expected to establish a multi-disciplinary study team that may include a variety of clinical specialists
to effectively address the proposed question.  Projects funded by this award will, if successful, ultimately change the standard of practice for decision-making in the treatment of primary
prostate cancer.
Interesting features of the Prostate Cancer Impact Award include: clinical trials allowed, emphasis on impact, must include preliminary data from laboratory of PI or member(s) of research
team to support feasibility of study,
Eligibility: Stanford faculty with PI eligibility
Amount of funding: maximum funding of $750,000 for direct costs plus indirect costs, for a period of performance of up to four (4) years.
Deadlines:
Pre-Application through http://cdmrp.org <http://cdmrp.org> required and due: March 17, 2010; 5 pm Eastern Time.
Pre-proposals (Pre-proposal narrative has a 2 page limit) and will be screened by peer review and submission of full application is by PCRP invitation).
Invitations from the PCRP to selected pre-applicants: April 19, 2010
Application due June 9, 2010, 11:59 pm EST via grants.gov

Idea Development Award
Purpose
: The PCRP Idea Development Award supports new ideas that represent innovative approaches to prostate cancer research and have the potential to make an important contribution to eliminating death and suffering from prostate cancer. Although groundbreaking research often involves a degree of risk, applications should be based on a sound scientific rationale that is established through logical reasoning and/or critical review and analysis of the literature. The PCRP seeks applications from the wide spectrum of basic to clinical research (excluding clinical trials), that are responsive to at least one of the PCRP overarching challenges and at least one of the PCRP focus areas.
See the program guidelines for 2010 research focus areas.
Amount of funding: maximum funding of $450,000 in direct costs (plus indirects) for up to 3 years
Eligibility:  Stanford faculty with PI eligibility
Deadlines:
Invitation to Submit an Application: April 21, 2010
Full application (by invitation only):  June 9, 2010 11:59 pm. EST  via grants.gov

Synergistic Idea Development Award
Purpose:
The PCRP Synergistic Idea Development Award supports new ideas that represent innovative approaches to prostate cancer research involving two or three independent, faculty-level (or equivalent) Principal Investigators (PIs). These investigators should use synergistic and complementary perspectives to address a central problem or question in prostate cancer research. This award is designed to encourage and support both new and pre-existing partnerships. The overall goal of this award is to significantly accelerate advances in prostate cancer research to support the PCRP vision of conquering prostate cancer. Although groundbreaking research often involves a degree of risk, applications should be based on a sound scientific rationale that is established through logical reasoning and/or critical review and analysis of the literature.  
The Synergistic Idea Development Award requires that multiple investigators jointly design a single project. However, each partner will be recognized as a PI, submit a separate application, and receive an individual award. The research project must be supported by the unique expertise of each PI, and it must clearly define the synergistic components that will facilitate and accelerate progress in a way that could not be accomplished through independent efforts. Multidisciplinary projects are encouraged, and multi-institutional projects are allowed.
See the program guidelines for 2010 research focus areas.
Amount of funding: maximum funding of $750,000 in direct costs (plus indirects) for up to 3 years
Eligibility:  Stanford faculty with PI eligibility
Deadlines:
Invitation to Submit an Application: April 21, 2010
Full application (by invitation only):  June 9, 2010 11:59 pm EST via grants.gov

James S. McDonnell Foundation
Studying Complex Systems or Brain Cancer Research
21st Century Science Inititative: Research Awards-up to $450,000 for up to 6 year
Deadline:  March 17, 2010
http://www.jsmf.org/apply/apply.php

The Sontag Foundation
Distinguished Scientist Award
(brain cancer research)
Assist. professors
Each Award consists of a four-year funding component totaling a maximum of $600,000. (3 to be awarded.)
Deadline:  March 24, 2010
http://www.sontagfoundation.org/grant_opps/grant_opps_dsa.htm <http://www.sontagfoundation.org/grant_opps/grant_opps_dsa.htm>

American Cancer Society
Miscellaneous funding mechanisms
Deadline:  April 1, 2010 via proposalcentral
http://www.cancer.org/docroot/RES/RES_5_1.asp?sitearea=RES

James S. McDonnell Foundation
Collaborative Activity Award
Letter of intent: accepted any time
Topics:  Complex Systems, Brain Cancer, Human Cognition
multi-institutional, possibly multi-disciplinary, multi-investigator, flexible budget, length flexible
http://www.jsmf.org/apply/collaborative/ <http://www.jsmf.org/apply/collaborative/>

NCMHD Innovative Faith-Based Approaches to Health Disparities Research (R21)
(RFA-MD-10-004)
National Center for Minority Health and Health Disparities
Application Receipt Date(s): March 17, 2010 http://grants.nih.gov/grants/guide/rfa-files/RFA-MD-10-004.html <http://grants.nih.gov/grants/guide/rfa-files/RFA-MD-10-004.html>

FY10 Ovarian Cancer Research Program (OCRP)
Pilot Award
The OCRP Pilot Award supports conceptually innovative, high-risk/high-reward research that could ultimately lead to critical discoveries or major advancements that will drive the field of ovarian cancer forward. Research priorities should include a testable hypothesis based on strong scientific rationale. Successful projects should provide a catalyst to expand or modify current thinking and/or approaches in ovarian cancer research. Preliminary data are not required, but are allowed. The strength of the proposal should be based on sound scientific rationale and logical reasoning. Clinical trials will not be supported by this award mechanism.
Amount of funding:  
Maximum of $200,000 in direct costs (plus indirects) for up to 3 years
Maximum funding of $250,000 for direct costs with a qualified nested Teal Pre-doctoral Scholar** (plus indirect costs).Period of performance not to exceed 2 yrs.
20 pilot award applications will be funded.
Eligibility:  Stanford faculty with PI eligibility
**For applications with an optional nested Teal Pre-doctoral Scholar:
A nested Teal Predoctoral Scholar is defined as a pre-doctoral student who is currently enrolled full time in an accredited doctoral program (e.g., Ph.D., M.D./Ph.D., D.Sc.) and who will have successfully completed comprehensive examinations or otherwise will have met pre-dissertation requirements by time of award.
Deadlines:
Pre-application: March 11, 2010, 5 pm EST via the CDMRP eReceipt system

Invitation to Submit an Application: April 2010
Full application (by invitation only):  June 10, 2010 11:59 pm. EST  via grants.gov

FY10 Prostate Cancer Research Program (PCRP)
Idea Development Award
The PCRP Idea Development Award supports new ideas that represent innovative approaches to prostate cancer research and have the potential to make an important contribution to eliminating death and suffering from prostate cancer. Although groundbreaking research often involves a degree of risk, applications should be based on a sound scientific rationale that is established through logical reasoning and/or critical review and analysis of the literature. The PCRP seeks applications from the wide spectrum of basic to clinical research (excluding clinical trials), that are responsive to at least one of the PCRP overarching challenges and at least one of the PCRP focus areas.
See the program guidelines for 2010 research focus areas.
Amount of funding: maximum funding of $450,000 in direct costs (plus indirects) for up to 3 years
Eligibility:  Stanford faculty with PI eligibility
Deadlines:
Pre-application:  March 3, 2010, 5 pm EST via the CDMRP eReceipt system

Invitation to Submit an Application: April 21, 2010
Full application (by invitation only):  June 9, 2010 11:59 p.m. EST  via grants.gov

Synergistic Idea Development Award
The PCRP Synergistic Idea Development Award supports new ideas that represent innovative approaches to prostate cancer research involving two or three independent, faculty-level (or equivalent) Principal Investigators (PIs). These investigators should use synergistic and complementary perspectives to address a central problem or question in prostate cancer research. This award is designed to encourage and support both new and pre-existing partnerships. The overall goal of this award is to significantly accelerate advances in prostate cancer research to support the PCRP vision of conquering prostate cancer. 

The Synergistic Idea Development Award requires that multiple investigators jointly design a single project. However, each partner will be recognized as a PI, submit a separate application and receive an individual award. The research project must be supported by the unique expertise of each PI, and it must clearly define the synergistic components that will facilitate and accelerate progress in a way that could not be accomplished through independent efforts. Multidisciplinary projects are encouraged, and multi-institutional projects are allowed.
See the program guidelines for 2010 research focus areas.
Amount of funding: maximum funding of $750,000 in direct costs (plus indirects) for up to 3 years
Eligibility:  Stanford faculty with PI eligibility
Deadlines:
Pre-application:  March 3, 2010,  5 p.m. EST via the CDMRP eReceipt system

Invitation to Submit an Application: April 21, 2010
Full application (by invitation only):  June 9, 2010 11:59 pm EST  via grants.gov

Small Grants Program for Cancer Epidemiology (R03) PAR-08-237
Application Due Date(s): March 19, 2010; July 23, 2010; Nov. 19, 2010; March 18, 2011; July 22, 2011; Nov. 18, 2011
http://grants.nih.gov/grants/guide/pa-files/PAR-08-237.html

Exploratory/Developmental Grants Program for Basic Cancer Research in Cancer Health Disparities (R21) PAR-09-160
Application Receipt Date(s): June 23, 2010; Nov. 23, 2010; June 23, 2011; Nov. 23, 2011
http://grants.nih.gov/grants/guide/pa-files/PAR-09-160.html

Translational Tools for Clinical Studies of CAM Interventions (R01)
(RFA-AT-10-001)
National Center for Complementary and Alternative Medicine
Letters of Intent Receipt Date(s): Not Applicable
Application Receipt Date(s): March 23, 2010
http://grants.nih.gov/grants/guide/rfa-files/RFA-AT-10-001.html

Development, Application, and Evaluation of Prediction Models for Cancer Risk and Prognosis (R01)
(PA-10-025)
National Cancer Institute
Application Receipt/Submission Date(s): Multiple dates, see announcement.
Standard R01 deadlines:  June 5; Oct. 5
Standard AIDS- AIDS-related deadlines: May 7; Sept. 7
http://grants.nih.gov/grants/guide/pa-files/PA-10-025.html

Development, Application, and Evaluation of Prediction Models for Cancer Risk and Prognosis (R21)
(PA-10-026)
National Cancer Institute
Application Receipt/Submission Date(s):Multiple dates, see announcement.
Exploratory/developmental (R21) grant mechanism
Standard R21 deadlines: June 16; Oct. 16
Standard AIDS- AIDS-related deadlines: May 7; Sept. 7
http://grants.nih.gov/grants/guide/pa-files/PA-10-026.html

Howard Hughes Medical Institute (HHMI)
Unlimited applicants are permitted.

You may apply to both the HHMI/NIH Research Scholars Program and the HHMI Research Training Fellowships for Medical Students in a given year. You may also apply to other NIH programs.

Epigenetic Approaches in Cancer Epidemiology (R01)
(PA-10-031)
National Cancer Institute
Application Receipt/Submission Date(s):  Multiple dates, see announcement.
Standard R01 deadlines: June 5; Oct. 5
http://grants.nih.gov/grants/guide/pa-files/PA-10-031.html

Epigenetic Approaches in Cancer Epidemiology (R21)
(PA-10-032)
National Cancer Institute
Application Receipt/Submission Date(s):  Multiple dates.

Cancer Prevention Research Small Grant Program (R03)
The NCI invites applications that propose small and time-limitedprojects pertinent to the development of cancer chemoprevention agents, biomarkers for early cancer detection, cancer-related nutrition science, and/or clinical prevention studies that focus on specific target organs.
Letter of intent: not applicable
Deadline:  March 19, 2010, via grants.gov*
http://grants.nih.gov/grants/guide/pa-files/PAR-08-055.html

Small Grants for Behavioral Research in Cancer Control (R03) PAR-09-003
Eligibility:  Stanford faculty with PI eligibility
Letter of intent:  not applicable
Deadline:  April 20, 2010, via grants.gov*
http://grants.nih.gov/grants/guide/pa-files/PAR-09-003.html

Small Grants for Behavioral Research in Cancer Control (R03) PAR-09-003
Application Due Date(s): April 20, 2010; Aug. 20, 2010; Dec. 20, 2010; April 20, 2011; Aug. 22, 2011; Dec. 20, 2011
http://grants.nih.gov/grants/guide/pa-files/PAR-09-003.html

Small Grants Program for Cancer Epidemiology (R03) PAR-08-237
Application Due Date(s): March 19, 2010; July 23 ,2010; Nov. 19, 2010; March 18, 2011; July 22, 2011; Nov. 18, 2011
http://grants.nih.gov/grants/guide/pa-files/PAR-08-237.html

Alphabetical List of Other NCI Funding Opportunities

Basic Cancer Research in Cancer Health Disparities (U01) PAR-09-161
Letters of Intent Receipt Date(s): Not Applicable
Application Receipt Date(s): June 23, 2010; Nov. 23, 2010; June 23, 2011
http://grants.nih.gov/grants/guide/pa-files/PAR-09-161.html

Biomarkers for Early Detection of Hematopoietic Malignancies (R01) PA-09-197
Standard R01

Application Submission/Receipt Date(s) apply:  June 5; Oct. 5
Expiration Date: Sept. 8, 2012
http://grants.nih.gov/grants/guide/pa-files/PA-09-197.html

Biomarkers for Early Detection of Hematopoietic Malignancies (R21)  PA-09-198
Standard R01

Application Submission/Receipt Date(s) apply:  June 16; Oct. 16
Expiration Date: Sept. 8, 2012
http://grants.nih.gov/grants/guide/pa-files/PA-09-198.html

Cancer Surveillance Using Health Claims-based Data System (R03)
PA-09-143

Standard R03
Application Submission/Receipt Date(s): June 16; Oct. 16
Expiration Date: May 8, 2012
http://grants.nih.gov/grants/guide/pa-files/PA-09-143.html

Cancer Surveillance Using Health Claims-based Data System (R03) PA-09-144
NIH Exploratory/Developmental (R21) grant mechanism
Standard R21

Application Submission/Receipt Date(s): June 16; Oct. 16
Expiration Date: May 8, 2012
http://grants.nih.gov/grants/guide/pa-files/PA-09-144.html

Cancer Surveillance Using Health Claims-based Data System (R03) PA-09-145
Standard R01

Application Submission/Receipt Date(s): June 5; Oct. 5
Expiration Date: May 8, 2012
http://grants.nih.gov/grants/guide/pa-files/PA-09-145.html

Collaborative Research in Integrative Cancer Biology and the Tumor Microenvironment (U01) PAR-09-026
Letters of Intent Receipt Dates: Sept. 19, 2010; Jan. 18, 2011; Sept. 19, 2011.
Application Due Dates:  Oct. 19, 2010; Feb.18, 2011; Oct. 19, 2011.
http://grants.nih.gov/grants/guide/pa-files/PAR-09-026.html

Development, Application, and Evaluation of Prediction Models for Cancer Risk and Prognosis (R01) PA-10-025
Standard R01 Application

Submission/Receipt Date(s): June 5; Oct. 5
Expiration Date: Jan. 8, 2013
http://grants.nih.gov/grants/guide/pa-files/PA-10-025.html

Development, Application, and Evaluation of Prediction Models for
Cancer Risk and Prognosis (R21) PA-10-026
NIH Exploratory/Developmental (R21) grant mechanism

Standard R21 Application
Submission/Receipt Date(s): June 16; Oct. 16
Expiration Date: Jan. 8, 2013
http://grants.nih.gov/grants/guide/pa-files/PA-10-026.html

Developmental Projects in Complementary Approaches to Cancer Care and Treatment (R21) PA-09-167
NIH Exploratory/Developmental (R21) grant mechanism
Standard R21
Application
Submission/Receipt Date(s): June 16; Oct. 16
Expiration Date: May 8, 2012
http://grants.nih.gov/grants/guide/pa-files/PA-09-167.html

Developmental Projects in Complementary Approaches to Cancer Care and
Treatment (R03) PA-09-168
Standard R03 Application

Submission/Receipt Date(s): June 16; Oct. 16
Expiration Date: May 8, 2012
http://grants.nih.gov/grants/guide/pa-files/PA-09-168.html

Developmental Research in Cancer Prognosis and Prediction (R21) PA-09-158
NIH Exploratory/Developmental (R21) grant mechanism
Standard R21
Application Submission/Receipt Date(s): June 16, Oct. 16
Expiration Date: May 8, 2012
http://grants.nih.gov/grants/guide/pa-files/PA-09-158.html

Developmental Research in Cancer Prognosis and Prediction (R33) PA-09-159
NIH Exploratory/Developmental Phase II Research Grant (R33 Standard R33
)
Application Submission/Receipt Date(s): June 16; Oct. 16
Expiration Date: May 8, 2012
http://grants.nih.gov/grants/guide/pa-files/PA-09-159.html

Diet, Epigenetic Events and Cancer Prevention (R01) PA-09-234
Standard R01

Application Submission/Receipt Date(s): June 5; Oct. 5
Expiration Date: Sept. 8, 2012
http://grants.nih.gov/grants/guide/pa-files/PA-09-234.html

Diet, Epigenetic Events and Cancer Prevention (R21) PA-09-235
NIH Exploratory/Developmental (R21) grant mechanism

Standard R21 Application Submission/Receipt Date(s): June 16; Oct. 16
Expiration Date: Sept. 8, 2012
http://grants.nih.gov/grants/guide/pa-files/PA-09-235.html

Diet-Induced Changes in Inflammation as Determinants of Colon Cancer
(R01) PA-08-210
Standard R01

Application Submission/Receipt Date(s): June 5; Oct. 5
Expiration Date: Sept. 8, 2011
http://grants.nih.gov/grants/guide/pa-files/PA-08-210.html

Diet-Induced Changes in Inflammation as Determinants of Colon Cancer
(R21) PA-08-211
NIH Exploratory/Developmental (R21) grant mechanism
Standard R21

Application Submission/Receipt Date(s): June 16; Oct. 16
Expiration Date: Sept. 8, 2011
http://grants.nih.gov/grants/guide/pa-files/PA-08-211.htm

Epigenetic Approaches in Cancer Epidemiology (R01) PA-10-031
Standard R01

Application Submission/Receipt Date(s): June 5; Oct. 5
Expiration Date: Jan. 8, 2013
http://grants.nih.gov/grants/guide/pa-files/PA-10-031.html

Epigenetic Approaches in Cancer Epidemiology (R21) PA-10-032
NIH Exploratory/Developmental (R21) grant mechanism
Standard R21

Application Submission/Receipt Date(s): June 16; Oct. 16
Expiration Date: Jan. 8, 2013
http://grants.nih.gov/grants/guide/pa-files/PA-10-032.html

Erythropoiesis Stimulating Agents and Tumor Progression (R01) PA-09-023
Standard R01

Application Submission/Receipt Date(s): June 5; Oct. 5
Expiration Date: Jan. 8, 2012
http://grants.nih.gov/grants/guide/pa-files/PA-09-023.html

Erythropoiesis Stimulating Agents and Tumor Progression (R21) PA-09-024
NIH Exploratory/Developmental (R21) grant mechanism
Standard R21

Application Submission/Receipt Date(s): June 16; Oct. 16
Expiration Date: Jan. 8, 2012
http://grants.nih.gov/grants/guide/pa-files/PA-09-024.html

Etiology, Prevention, and Treatment of Hepatocellular Carcinoma (P01)
PAR-09-147

The primary focus of the proposed projects must be on the basic biology, prevention, and/or treatment of liver cancer.
Letters of Intent Receipt Date(s): April 28, 2010; Aug. 28, 2010; Dec. 28, 2010; and April 27, 2011
Application Due Date(s): May 28, 2010; Sept. 28, 2010; Jan. 28, 2011; and May 27, 2011
http://grants.nih.gov/grants/guide/pa-files/PAR-09-147.html

Etiology, Prevention and Treatment of Hepatocellular Carcinoma (R01) PA-08-243
Standard R01

Application Submission/Receipt Date(s) apply:  June 5; Oct. 5
Expiration Date: Sept. 8, 2011
http://grants.nih.gov/grants/guide/pa-files/PA-08-243.htm

Etiology, Prevention, and Treatment of Hepatocellular Carcinoma (R21) PA-08-244
NIH Exploratory/Developmental (R21) grant mechanism
Standard R21

Application Submission/Receipt Date(s): June 16; Oct. 16
Expiration Date: Sept. 8, 2011
http://grants.nih.gov/grants/guide/pa-files/PA-08-244.html

Exfoliated Cells and Circulating DNA in Cancer Detection and
Diagnosis (R21) PA-09-238
NIH Exploratory/Developmental (R21) grant mechanism
Standard R21

Application Submission/Receipt Date(s): June 16; Oct. 16
Expiration Date: Sept. 8, 2012
http://grants.nih.gov/grants/guide/pa-files/PA-09-238.html

Exploratory Cancer Prevention Studies Involving Molecular Targets for
Bioactive Food Components (R21) PA-07-362NCI, NIA, ODS

Remaining Application Submission/Receipt Date(s): Feb. 16, 2010
Expiration Date: March 17, 2010
http://grants.nih.gov/grants/guide/pa-files/PA-07-362.html

Exploratory/Developmental Grants Program for Basic Cancer Research in Cancer Health Disparities (R21) PAR-09-160
Letters of Intent Receipt Date: Not Applicable
Application Receipt Date(s): June 23, 2010; Nov. 23, 2010; June 23, 2011; Nov. 23, 2011
http://grants.nih.gov/grants/guide/pa-files/PAR-09-160.html

Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research (R21) PAR-09-162
Letters of Intent Receipt Date(s): May 23, 2010; Oct. 23, 2010; May 23, 2011; Oct. 23, 2011
Application Due Date(s): June 23, 2010, Nov. 23, 2010; June 23, 2011; Nov. 23, 2011
http://grants.nih.gov/grants/guide/pa-files/PAR-09-162.html

Exploratory Grants for Behavioral Research in Cancer Control (R21) PA-09-130
Standard R21

Application Submission/Receipt Date(s): June 16; Oct. 16
Expiration Date: May 8, 2012
http://grants.nih.gov/grants/guide/pa-files/PA-09-130.html

Exploratory Studies in Cancer Detection, Diagnosis, and Prognosis (R21) PA-08-267
Standard R21

Application Submission/Receipt Date(s): 16; June 16; Oct. 16
Expiration Date: Sept. 8, 2012
http://grants.nih.gov/grants/guide/pa-files/PA-08-267.html

Exploratory/Developmental Grants Program for Basic Cancer Research in Cancer Health Disparities (R21) PAR-09-160
Application Receipt Date(s): June 23, 2010; Nov. 23, 2010; June 23, 2011; Nov. 23, 2011
http://grants.nih.gov/grants/guide/pa-files/PAR-09-160.html

Basic Cancer Research in Cancer Health Disparities (U01) PAR-09-161
Application Receipt Date(s): June 23, 2010; Nov. 23, 2010; June 23, 2011; Nov. 23, 2011
http://grants.nih.gov/grants/guide/pa-files/PAR-09-161.html

Geographic and Contextual Influences on Energy Balance-Related Health Behaviors (R01) PA-08-192 NCI, NHLBI, NINR, NICHD, OBSSR
Standard R01

Application Submission/Receipt Date(s) apply: June 5; Oct. 5
Expiration Date: Sept. 8, 2011
http://grants.nih.gov/grants/guide/pa-files/PA-08-192.htm

Geographic and Contextual Influences on Energy Balance-Related Health Behaviors (R21) PA-08-193 NCI, NHLBI, NINR, NICHD, OBSSR
NIH Exploratory/Developmental (R21) grant mechanism
Standard R21

Application Submission/Receipt Date(s) apply:  June 16; Oct. 16
Expiration Date: Sept. 8, 2011
http://grants.nih.gov/grants/guide/pa-files/PA-08-193.html

Stanford-NIH K Award Resource Webpage
http://ora.stanford.edu/grantsgov/nih_k_award.asp
This webpage was developed by Lisa Forgatsch in the Office of Research Administration and contains specific support materials for your NIH Grants.gov K award proposals, including application tools, NIH e Commons User name, training and protocol resources, software resources, online materials, required forms.
 
NIH K Award Kiosk
List of available K award mechanisms**
http://grants.nih.gov/training/careerdevelopmentawards.htm

Additional K award information for postdoctoral fellows:
http://med.stanford.edu/rmg/fellowships.html#kawards

Grants.gov@Stanford resources Setting up your computer, eSubmit, etc.
http://ora.stanford.edu/grantsgov/default.asp

NIH Guide Funding Opportunity Search Tool
http://grants.nih.gov/grants/guide/

New Investigator Guide to NIH funding
(A NIAID tool for all investigators)
http://www.niaid.nih.gov/ncn/grants/new/default.htm

RMG Funding Information Web Resources webpage
http://med.stanford.edu/rmg/funding/

 

 

Stanford Medicine Resources:

Footer Links: